4.Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305–315.PubMed
5.Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney RM, Denollet J, et al. Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data metaanalysis. Br J Psychiatry 2013;203:90–102.PubMed CrossRef
6.van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814–822.PubMed CrossRef
7.Zhang JM, Liang JZ, Gu NF. The interactions of antidepressant drugs. Chin J Clin Pharm (Chin) 2004;13:316–320.
8.World Health Organization. International statistical classification of diseases and related health problems (10th revision). Available at: http://​www.​ who.int/classifications/icd/en/
9.Chinese Society of Psychiatry. Chinese classification of mental disorders. Jinan: Shandong Science and Technology Press; 2001:87–89.
10.Hamilton MJ. Neurology neurosurgery and psychiatry. 1960;23:56–62.CrossRef
11.Cao ZD, Mao JL, Bao ZX. Treatment of depression in patients with CAD by therapy of nourishing Liver and Kidney. J Chengdu Univ Tradit Chin Med (Chin) 2006;29:25–28.
12.Cao ZD, Mao JL, Bao ZY, Wu SB. Clinical observation on the therapeutic effect of Tongxinluo Capsule on depression in patients with coronary heart disease. Chin J Difficult Complic Cases (Chin) 2006;5:251–253.
13.He JW, Hu QH, Li T, Wang LQ, Sun FJ, Wang BB. Observation of combination therapy of paroxetine and Xuefu Zhuyu Decoction on coronary heart disease complicating with depression in elder patients. Modern J Integr Tradit Chin West Med (Chin) 2013;22:3081–3082, 3092.
14.Li X, Tong LG. The effects of Jiawei Ganmai Dazao Decoction on treating 32-cases depression following percutaneous coronary intervention. Zhejiang J Tradit Chin Med (Chin) 2008;43(2):88–89.
15.Min XM. The therapeutic effect of Shensong Yangxin Capsule combined with deanxit in treatment of depression following myocardial infarction curative effect observation. Guide China Med (Chin) 2013;11:406–407.
16.Qin HW, Liu P. Coronary heart disease-related depression integrative medicine research. Acta Neuropharmacol (Chin) 2012;2:1–4
17.Shang XM, Zeng QM, Jing GG, Jiang LF, Wang H. The effects of Modified Chaihu Longgu Muli Decoction in treating 30 cases depression following percutaneous coronary intervention. Guid J Tradit Chin Med Pharm (Chin) 2014;20:43–44.
18.Shao J, Sun XZ. The observation on the therapeutic effect of Jieyu Decoction on depression in patients with coronary heart disease. Clin J Tradit Chin Med (Chin) 2007;19:12–13.
19.Shao J, Peng TT. The observation on the clinical effect of Shugan Jieyu Decoction on depression of coronary heart disease with ventricular arrhythmia. Chin J Basic Med Tradit Chin Med (Chin) 2009;15:964–965.
20.Yang JH. The observation on the clinical effect of Shugan Jieyu Decoction on 66-cases depression of coronary heart disease. Guid J Tradit Chin Med Pharm (Chin) 2010;16:22–24.
21.Zhang LF. Syndrome characteristics and Chinese medicine intervention clinical research of coronary heart disease combine with depression [dissertation]. Beijing: Beijing University of Traditional Chinese Medicine; 2011.
22.Zhu F. The clinical research of Jieyu particle in treatment of unstable angina patients with depression status [dissertation]. Jinan: Shandong University of Traditional Chinese Medicine; 2008.
23.Ni DM, Ban WM, Wang CL, Chen GR, Fu XK, Ma YQ, et al. Clinical research on Shuxin Jieyu decoction treating coronary heart disease with depression. J Emerg Tradit Chin Med (Chin) 2014;23:835–836, 843.
24.Jiao Y, Li SW, Shang QH, Xu H. Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease. Chin J Integr Med 2014;20:341–346.PubMed CrossRef
25.Liu HX, Wang ZY. 113 patients with coronary angiography syndromes and imaging characteristics analysis. J China-Japan Friendship Hosp (Chin) 2006;20:37.
26.Yu G, Wang J. Blood stasis syndrome of coronary heart disease: a perspective of modern medicine. Chin J Integr Med 2014;20:300–306.CrossRef
27.Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: Greater precision but with greater uncertainty. JAMA 2003;289:2554–2559.PubMed CrossRef
28.Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 2001;135:982–989.PubMed CrossRef
29.Dobs G, Tao I. The model of Western integrative medicine: the role of Chinese medicine. Chin J Integr Med 2011;17:11–20.CrossRef
30.Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726–732.PubMed CrossRef
31.Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann of Intern Med 2006;144:364–367.CrossRef
32.Xing L, Robinson N. Methodological approaches to developing and establishing the body of evidence on postmarketing Chinese medicine safety. Chin J Integr Med 2013;19:494–497.CrossRef
33.Wang JY. Significance of evidence-based medicine in the assessment of Chinese medicine clinical efficacy. Chin J Integr Med 2010;16:392–393.PubMed CrossRef
34.Chen KJ, Song J. The raising of evidence-based medicine inspires the integration of traditional and Western medicine. Chin J Integr Med 2000;6:242–243.

作者单位：An-lu Wang 王安璐 (1)
Zhuo Chen 陈 卓 (1)
Jing Luo 罗 静 (1)
Qing-hua Shang 尚青华 (2)
Hao Xu 徐 浩 (2)

1. Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China
2. Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China

刊物主题：Medicine/Public Health, general;

出版者：Springer Berlin Heidelberg

ISSN：1993-0402

文摘

Objectives This systemic review evaluated the efficacy and safety of Chinese herbal medicines (CHMs) in patients with coronary heart disease (CHD) complicated with depression.